TABLE 1.
Clinical and pathological data for 40 testicular germ cell tumor cases
| Patient no.* | Age | pTNM | Histology |
|---|---|---|---|
| 1 | 26 | pT1NXMX | ITGCN, S |
| 2 | 26 | pT1NXMX | ITGCN, S |
| 3 | 37 | pT1NXMX | S |
| 4 | 33 | pT1NXMX | ITGCN, S |
| 5 | 31 | pT1NXMX | ITGCN, S |
| 6 | 29 | pT1NXMX | ITGCN, S |
| 7 | 39 | pT1NXMX | ITGCN, S |
| 8 | 27 | pT3NXMX | S |
| 9 | 41 | pT1NXMX | ITGCN, S |
| 10 | 48 | pT1NXMX | S |
| 11 | 48 | pT2NXMX | S |
| 12 | 34 | pT1NXMX | ITGCN, S |
| 13 | 60 | pT1NXMX | ITGCN, S |
| 14 | 29 | pT1NXMX | ITGCN, S |
| 15 | 60 | pT1NXMX | S |
| 16 | 29 | pT1NXMX | ITGCN, S |
| 17 | 28 | pT1NXMX | ITGCN, S |
| 18 | 32 | pT1NXMX | ITGCN, S |
| 19 | 37 | pT1NXMX | EC |
| 20 | 18 | pT2NXMX | EC, IT, MT, S |
| 21 | 24 | pT1NXMX | EC, ITGCN, S |
| 22 | 22 | pT2NXMX | EC, YST |
| 23 | 37 | pT1NXMX | EC, ITGCN, S |
| 24 | 28 | pT2NXMX | C, EC, IT, MT |
| 25 | 17 | pT2NXMX | EC, MT |
| 26 | 34 | pT2NXMX | EC |
| 27 | 19 | pT1NXMX | EC, ITGCN, MT, YST |
| 28 | 39 | pT1NXMX | MT, YST |
| 29 | 21 | pT2NXMX | EC, MT, YST |
| 30 | 23 | pT2NXMX | EC, IT, MT |
| 31 | 22 | pT1NXMX | MT, YST |
| 32 | 25 | pT3NXMX | EC |
| 33 | 45 | pT2NXMX | EC, ITGCN, S, YST |
| 34 | NK | pT2NXMX | C, EC, ITGCN, S, YST |
| 35 | 23 | pT2NXMX | EC, IT, ITGCN, MT, YST |
| 36 | 39 | pT1NXMX | EC, ITGCN, S, YST |
| 37 | 24 | pT2NXMX | EC, ITGCN, YST |
| 38 | 30 | pT1NXMX | EC, ITGCN, YST |
| 39 | 36 | pT1NXMX | EC, ITGCN, MT, YST |
| 40 | 58 | pT2NXMX | EC, ITGCN, YST |
*
seminomas, patients no. 1–18; nonseminomas, pateints no. 19–40
C = choriocarcinoma; EC = embryonal carcinoma; IT = immature teratoma; ITGCN = intratubular germ cell neoplasia; MT = mature teratoma; S = seminoma; YST = yolk sac tumor; NK = not known